Load Modification Versus Standard Exercise for Greater Trochanteric Pain Syndrome (GLAM)

January 13, 2023 updated by: Stephanie Di Stasi, Ohio State University

Load Modification Versus Standard Exercise to Inform Treatment for Individuals With Greater Trochanteric Pain Syndrome

Greater trochanteric pain syndrome (GTPS), or lateral hip pain, is associated with muscle weakness, altered movement patterns and painful daily activities. The disability associated with GTPS is comparable to end stage hip osteoarthritis, primarily affecting young and middle aged women. Few non-operative treatments have demonstrated long-term lasting or satisfactory results. For those who do improve, recurrence rates of pain and disability can be as high as 50%.

Gluteal tendinopathy is the most common condition associated with a GTPS diagnosis. High compressive loads of the gluteal tendons during common activities like walking, stair-climbing, and running are the theorized mechanism for GTPS. These compressive loads are exacerbated with postures and movement patterns that involve the lateral tilting of the pelvis or movement of the thigh across the midline of the body. There is recent evidence that load modification through education and exercise is superior to a corticosteroid injection for reducing pain in these patients. However, it is unknown whether the possible effects of the load modification program were due to exercise alone or the reduction in compressive loads. As current physical therapy interventions for GTPS commonly incorporate high load postures and exercise activities, there is an urgent need to compare outcomes of standard of care physical therapy to load modification.

The goal of this study is to evaluate the short-term effects of load modification education on pain and function in individuals with GTPS. Participants will be randomized to receive either standard exercise education or load modification education. Both groups will complete a series of questionnaires about their pain and function, and undergo a brief 2-dimensional assessment of their posture and movement. Between follow-up sessions, participants will be asked to respond to brief weekly online surveys to document their home program compliance, pain, and function. It is hypothesized that the group of participants receiving load modification will have the highest proportion of individuals with significant improvements in pain and function, and will demonstrate improved posture and movement.

Study Overview

Study Type

Interventional

Enrollment (Actual)

62

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Ohio
      • Columbus, Ohio, United States, 43202
        • Jameson Crane Sports Medicine Institute

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 70 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria: Unilateral diagnosis of GTPS, as confirmed by physician using the following criteria:

  • Lateral hip pain, worst over greater trochanter, for >/= 3 months
  • Pain with palpation over greater trochanter
  • Average pain intensity of >/= 4/10 most days of the week
  • Lateral hip pain reproduced during a 30 second single leg stance, or at least one of the following positive tests:

    1. >/= 2/10 lateral hip pain reproduce with passive hip flexion, adduction, and external rotation (ie. FADER)
    2. lateral hip pain reproduced with resisted internal rotation in the passive hip flexion, adduction, and external rotation position (ie. FADER-R)
    3. lateral hip pain reproduce with overpressure into passive hip adduction in sidelying (ie. ADD)
    4. lateral hip pain reproduced with resisted hip abduction in the hip hip adducted position (ie. ADD-R)
    5. lateral hip pain reproduced with hip flexion, abduction, external rotation (ie. FABER)

      Exclusion Criteria:

    1. Any of the following treatments within the last 3 months:

      1. corticosteroid injection in the affected hip
      2. physical therapy or other skilled exercise intervention by a medical or rehabilitation professional
    2. Any of the following concomitant impairments or conditions:

      a) Known or observed advanced spine, hip, knee, or ankle joint pathology, including: i. Spinal or lower extremity surgery within the last 6 months ii. Imaging data showing Kellgren Lawrence grade >/=2 in any lower extremity joint with concurrent complaint >/=2/10 most days of the week.

      iii. Groin pain as the primary hip pain complaint >/=2/10 most days of the week.

      iv. <90 degrees of active hip and knee flexion bilaterally v. <0 degrees of active ankle dorsiflexion

      b) Systemic inflammatory diseases, or any systemic disease that affects the nervous or musculoskeletal system or uncontrolled diabetes, or active malignancy c) Individuals who cannot tolerate or should not assume the positions required for the exercises for any reason other than hip discomfort

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Load modification education
Load modification education includes exercises currently prescribed by physical therapists, like stretching and strengthening activities, but will also include education on common daily postures and movement patterns that may increase load and stress on the muscles and tendons around the hip.
Load modification education includes exercises currently prescribed by physical therapists, like stretching and strengthening activities, but will also include education on common daily postures and movement patterns that may increase load and stress on the muscles and tendons around the hip.
Other Names:
  • Load modification
Active Comparator: Standard exercise education
Standard exercise education includes exercises currently prescribed by physical therapists, like stretching and strengthening activities.
Standard exercise education includes exercises currently prescribed by physical therapists, like stretching and strengthening activities.
Other Names:
  • Standard exercise

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Global Rating of Change
Time Frame: 4 weeks after enrollment
Participant perception of functional change, measured on an 11-point likert scale
4 weeks after enrollment
Change in Numeric Pain Rating Scale
Time Frame: at the time of enrollment and 4 weeks after enrollment
Participant perception of best and worst hip pain in the last week, on an 11 point scale
at the time of enrollment and 4 weeks after enrollment

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Pain Self-Efficacy Questionnaire (PSEQ)
Time Frame: at the time of enrollment and 4 weeks after enrollment
10-question survey about confidence with activities of daily living, using a 7-point likert scale
at the time of enrollment and 4 weeks after enrollment
Change in Victorian Institute of Sport Assessment for Greater trochanteric pain syndrome (VISA-G)
Time Frame: at the time of enrollment and 4 weeks after enrollment
8 questions asking about severity of functional limitation based on the participant's hip pain
at the time of enrollment and 4 weeks after enrollment
Change in Patient Reported Outcomes Measurement Information System (PROMIS) Bank v2.0 Physical Function
Time Frame: at the time of enrollment and 4 weeks after enrollment
Assesses physical function of participants using computerized adaptive testing techniques
at the time of enrollment and 4 weeks after enrollment
Change in Tegner Activity Level Scale
Time Frame: at the time of enrollment and 4 weeks after enrollment
Activity scale with 11 options ranging from complete disability to national elite level sports
at the time of enrollment and 4 weeks after enrollment
Patient Acceptable Symptomatic State question
Time Frame: 4 weeks after enrollment
A single question (yes/no response) asking participants whether or not they are satisfied with their current state, considering all daily activities, their level of pain, and perceived functional impairment
4 weeks after enrollment

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Stephanie Di Stasi, PhD, PT, Ohio State University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 17, 2018

Primary Completion (Actual)

March 14, 2022

Study Completion (Actual)

September 30, 2022

Study Registration Dates

First Submitted

June 18, 2018

First Submitted That Met QC Criteria

June 18, 2018

First Posted (Actual)

June 28, 2018

Study Record Updates

Last Update Posted (Estimate)

January 16, 2023

Last Update Submitted That Met QC Criteria

January 13, 2023

Last Verified

January 1, 2023

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 2017H0450

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

Undecided

IPD Plan Description

At this time, individual participant data (IPD) will be shared only with researchers listed on the funding associated with this project and the Institutional Review Board list of approved key personnel. Deidentified IPD will be made available upon request for purposes of manuscript review and submission. Deidentified IPD may be made available to individuals upon request.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Pain

Clinical Trials on Load modification education

3
Subscribe